// App-Quantinova.ai

: Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY

Researchers

Presenter

  • Dave Singh

Principal Investigators

  • Leonardo Fabbri

  • Alberto Papi

  • Stefano Vezzoli

  • Annamaria Muraro

  • Stefano Petruzzelli

  • Mario Scuri

  • Jorgen Vestbo

Medical Centers

  • University of Manchester, Manchester, United Kingdom

  • University Hospital of Siena, Siena, Italy

  • University of Ferrara, Ferrara, Italy

  • Chiesi Pharmaceuticals, Parma, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved